Octamer Inc. is company
developing novel pharmaceuticals directed against AIDS, human cancers,
glaucoma, and chronic inflammatory diseases. The company's lead investigator
is Dr. Ernest Kun and is headquartered in Berkeley, CA. The keywords are
medical, health, science, pharmaceutical, drug, research, development,
AIDS, HIV, anti-, cancer, glaucoma, zinc, Kun, DIME, ADPRT, NOBA, NIBA,
FDA, and biotechnology
Oops! This document requires a browser with FRAMES
support, such as Netscape
2.0.
-- Others browsers can see the
same pages without the FRAMES interface.